National Trial of CGM in Pregnant Women With Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT06903728

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06903728
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06903728. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
National Trial of CGM in Pregnant Women With Type 2 Diabetes
Condition
Pregnancy
Intervention (Device)
continous glucose monitoring
Lead sponsor
Odense University Hospital (class: other)
Collaborator
Steno Diabetes Center Odense (class: other)
Collaborator
Steno Diabetes Center Copenhagen (class: other)
Collaborator
Aarhus University Hospital (class: other)
Collaborator
Steno Diabetes Center Nordjylland (class: other)

Record details

Record id
cardio:ct-nct06903728
Content hash
414edfaf040023536a04779a0425d0f21bc667ecb88bd3a9c39c98535581c6a3